{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:41:11Z","timestamp":1790646071477,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1748,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ajpath.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T17:11:45Z","timestamp":1419873105000},"page":"651-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["\u03b1-Galactosidase A Knockout Mice"],"prefix":"10.1016","volume":"185","author":[{"given":"Dinesh S.","family":"Bangari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Ashe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Piepenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Budman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.11.004_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ajpath.2014.11.004_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib3","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","article-title":"Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy","volume":"119","author":"Thurberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2014.11.004_bib4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","article-title":"Monitoring the 3-year efficacy of enzyme replacement therapy in Fabry disease by repeated skin biopsies","volume":"122","author":"Thurberg","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2014.11.004_bib6","series-title":"Fabry Disease","first-page":"39","article-title":"Subcellular, cellular and organ pathology of Fabry disease","author":"Elleder","year":"2010"},{"key":"10.1016\/j.ajpath.2014.11.004_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2014.11.004_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib11","first-page":"1978","article-title":"[Atypical phenotype of Fabry disease. Evidence of a new mutation]","volume":"29","author":"Derouiche","year":"2000","journal-title":"French. Presse Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.11.004_bib13","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl","key":"10.1016\/j.ajpath.2014.11.004_bib14","first-page":"A208","article-title":"Generation of a mouse model with \u03b1\u2212galactosidase A deficiency (abstract)","volume":"59","author":"Wang","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.11.004_bib15","doi-asserted-by":"crossref","first-page":"e15033","DOI":"10.1371\/journal.pone.0015033","article-title":"Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease","volume":"5","author":"Marshall","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.11.004_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-006-0473-y","article-title":"Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment","volume":"30","author":"Heare","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10430340252939041","article-title":"Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease","volume":"13","author":"Ziegler","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajpath.2014.11.004_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.mt.6300066","article-title":"Correction of the biochemical and functional deficits in Fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A","volume":"15","author":"Ziegler","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajpath.2014.11.004_bib19","series-title":"Pathology of Genetically Engineered Mice","first-page":"161","article-title":"Pathology of mice commonly used in genetic engineering (C57Bl\/6;129;B6,129; and FVB\/n)","author":"Ward","year":"2000"},{"key":"10.1016\/j.ajpath.2014.11.004_bib20","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2014.11.004_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2003.09.022","article-title":"Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications","volume":"43","author":"Meehan","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1066896911428737","article-title":"Colonic involvement in Fabry disease","volume":"19","author":"Deniz","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry\u2019s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/01913129209074564","article-title":"The ultrastructural spectrum of lysosomal storage diseases","volume":"16","author":"Iancu","year":"1992","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.11.004_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00697017","article-title":"Neuropathological and biochemical studies in Fabry\u2019s disease","volume":"30","author":"Tabira","year":"1974","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","article-title":"Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice","volume":"33","author":"Rodrigues","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","volume":"85","author":"Banikazemi","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajpath.2014.11.004_bib30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/pgmj.67.788.584","article-title":"Colonic involvement in Fabry\u2019s disease","volume":"67","author":"Jack","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajpath.2014.11.004_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00296520","article-title":"A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier","volume":"90","author":"Uchino","year":"1995","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2014.11.004_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00418-008-0417-8","article-title":"Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system","volume":"130","author":"Kolling","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jgm.468","article-title":"Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors","volume":"6","author":"Przybylska","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.ajpath.2014.11.004_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.2003.tb00222.x","article-title":"Sequelae of storage in Fabry disease-pathology and comparison with other lysosomal storage diseases","volume":"92","author":"Elleder","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ajpath.2014.11.004_bib37","first-page":"98","article-title":"[End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease]","volume":"43","author":"Teraguchi","year":"2004","journal-title":"J Cardiol"},{"key":"10.1016\/j.ajpath.2014.11.004_bib38","doi-asserted-by":"crossref","first-page":"e36373","DOI":"10.1371\/journal.pone.0036373","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.11.004_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1139\/o81-057","article-title":"The glycosphingolipids of human plasma lipoproteins","volume":"59","author":"Clarke","year":"1981","journal-title":"Can J Biochem"},{"key":"10.1016\/j.ajpath.2014.11.004_bib40","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1194\/jlr.M006759","article-title":"Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors","volume":"51","author":"Schweppe","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2014.11.004_bib41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0022-2275(20)37904-9","article-title":"Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus","volume":"24","author":"Camus","year":"1983","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2014.11.004_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/IAI.00679-08","article-title":"Shiga toxin 2 targets the murine renal collecting duct epithelium","volume":"77","author":"Psotka","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpath.2014.11.004_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/pgmj.72.848.380","article-title":"Tingling extremities in a young man","volume":"72","author":"Goldsmith","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajpath.2014.11.004_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/507705","article-title":"Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli","volume":"194","author":"Cilmi","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2014.11.004_bib45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/glycob\/cwj015","article-title":"Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products","volume":"15","author":"Fujii","year":"2005","journal-title":"Glycobiology"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2014.11.004_bib46","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0304-3959(99)00135-9","article-title":"Unexplained peculiarities of the dorsal root ganglion","volume":"82","author":"Devor","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ajpath.2014.11.004_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2014.11.004_bib48","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10545-012-9547-1","article-title":"Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation","volume":"36","author":"Chien","year":"2013","journal-title":"J Inherit Metab Dis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014006725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014006725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:45:31Z","timestamp":1757601931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014006725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0002944014006725"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.004","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Galactosidase A Knockout Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}